| Page | Article - [Author(s)] | PDF | Abs. | CME | Audio | Media |
|---|
| Full Paper |
|---|
CER1913 1999,17,6,Suppl.18 Pg. 0002-0007 | Does partial control of inflammation prevent long-term joint damage? Clinical rationale for combination therapy with multiple disease-modifying antirheumatic drugs T. Pincus, F.C. Breedveld, P. Emery › Free to View |  |  | | | |
|
CER1914 1999,17,6,Suppl.18 Pg. 0008-0012 | Early developments in combination therapy D.L. Scott, S. Farrow, S.I. Yeo › Free to View |  |  | | | |
|
CER1915 1999,17,6,Suppl.18 Pg. 0013-0019 | Pyramids to myriads: The combination conundrum in rheumatoid arthritis D. O`Gradaigh, D.G.I. Scott › Free to View |  |  | | | |
|
CER1916 1999,17,6,Suppl.18 Pg. 0020-0028 | Mechanisms of action of second-line agents and choice of drugs in combination therapy E. Choy, G. Panayi › Free to View |  |  | | | |
|
CER1917 1999,17,6,Suppl.18 Pg. 0029-0036 | Pharmacotherapeutic strategies for disease-modifying antirheumatic drug (dmard) combinations to treat rheumatoid arthritis (RA) T. Münster, D.E. Furst › Free to View |  |  | | | |
|
CER1918 1999,17,6,Suppl.18 Pg. 0037-0042 | New approaches to imaging of early rheumatoid arthritis P.G. Conaghan, D. McGonagle, R. Wakefield, P. Emery › Free to View |  |  | | | |
|
CER1919 1999,17,6,Suppl.18 Pg. 0043-0046 | Methotrexate and emerging therapies J.M. Kremer › Free to View |  |  | | | |
|
CER1920 1999,17,6,Suppl.18 Pg. 0047-0052 | Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate C.M. Stein, T. Pincus › Free to View |  |  | | | |
|
CER1921 1999,17,6,Suppl.18 Pg. 0053-0058 | Combination DMARD therapy with hydroxychloroquine, sulfasalzine, and methotrexate J.R. O › Free to View |  |  | | | |
|
CER1922 1999,17,6,Suppl.18 Pg. 0059-0065 | Combination DMARD therapy including corticosteroids in early rheumatoid arthritis T.T. Möttönen, P.J. Hannonen, M. Boers › Free to View |  |  | | | |
|
CER1923 1999,17,6,Suppl.18 Pg. 0066-0068 | Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis P.J. Mroczkowski, M.E. Weinblatt, J.M. Kremer › Free to View |  |  | | | |
|
CER1924 1999,17,6,Suppl.18 Pg. 0069-0072 | Etanercept and methotrexate combination therapy A.D. Bankhurst › Free to View |  |  | | | |
|
CER1925 1999,17,6,Suppl.18 Pg. 0073-0077 | Combination therapy of the chimeric monoclonal anti-tumor necrosis factor α antibody (infliximab) with methotrexate in patients with rheumatoid arthritis C. Antoni, J.R. Kalden › Free to View |  |  | | | |
|
CER1926 1999,17,6,Suppl.18 Pg. 0078-0082 | Use of combination therapy in the routine care of patients with rheumatoid arthritis: Physician and patient surveys D.J. Hawley, F. Wolfe, T. Pincus › Free to View |  |  | | | |
|
CER1927 1999,17,6,Suppl.18 Pg. 0083-0090 | Combination DMARD treatment with parenteral gold and methotrexate R. Rau › Free to View |  |  | | | |
|
CER1928 1999,17,6,Suppl.18 Pg. 0091-0094 | Clinical experience with combination disease-modifying antirheumatic drug therapy with cyclosporine K. Johns, G. Littlejohn › Free to View |  |  | | | |
|
CER1929 1999,17,6,Suppl.18 Pg. 0095-0101 | Aim for remission or "personal best" using combination DMARD therapy with methotrexate and hydroxychloroquine Wm. Bensen, W. Bensen › Free to View |  |  | | | |
|
CER1930 1999,17,6,Suppl.18 Pg. 0103-0104 | Combination cyclosporine and (hydroxy)chloroquine in rheumatoid arthritis B.A.C. Dijkmans, R.B.M. Landewé, B.E.E.M. van den Borne, F.C. Breedveld › Free to View |  |  | | | |
|
CER1931 1999,17,6,Suppl.18 Pg. 0105-0114 | TNFα and IL-1β are separate targets in chronic arthritis W.B. van den Berg, L.A.B. Joosten, F.A.J. van de Loo › Free to View |  |  | | | |
|
CER1932 1999,17,6,Suppl.18 Pg. 0115-0120 | Combination therapy with DMARDs and biological agents in collagen-induced arthritis R.O. Williams, A.-M. Malfait, D.M. Butler, M.J. Walmsley, M. Feldmann, R.N. Maini › Free to View |  |  | | | |
|
CER1933 1999,17,6,Suppl.18 Pg. 0121-0124 | Combination biologic therapy J.D. Isaacs, A.W. Morgan, V. Strand › Free to View |  |  | | | |